We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+18.99%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13.3B
AUM Growth
+$2.87B
Cap. Flow
+$1.1B
Cap. Flow %
8.24%
Top 10 Hldgs %
20.04%
Holding
2,557
New
285
Increased
1,225
Reduced
862
Closed
103

Sector Composition

Rank Sector Weight
1 Technology 8.95%
2 Consumer Discretionary 4.49%
3 Healthcare 4.46%
4 Financials 4.28%
5 Communication Services 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVL
2526
DELISTED
First TrustValue Line 100 Exchange-Traded
FVL
-23,435
Closed -$421K
MNK
2527
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
-14,874
Closed -$29K
EUMV
2528
DELISTED
iShares Edge MSCI Min Vol Europe ETF
EUMV
-15,236
Closed -$336K
EGIF
2529
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
-11,197
Closed -$119K
CHK
2530
DELISTED
Chesapeake Energy Corporation
CHK
-1,089
Closed -$38K
LK
2531
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
-33,120
Closed -$901K
JPGE
2532
DELISTED
JPMorgan Diversified Return Global Equity ETF
JPGE
-9,804
Closed -$469K
JPLS
2533
DELISTED
JPMorgan Long/Short ETF
JPLS
-16,737
Closed -$307K
CSFL
2534
DELISTED
CenterState Bank Corporation Common Stock
CSFL
-98,223
Closed -$1.69M
TUES
2535
DELISTED
Tuesday Morning Corp
TUES
-43,400
Closed -$25K
JCP
2536
DELISTED
J.C. Penney Company, Inc.
JCP
-19,665
Closed -$7K
AGN
2537
DELISTED
Allergan plc
AGN
-12,776
Closed -$2.26M
JMF
2538
DELISTED
NUVEEN ENERGY MLP TOTAL RETURN FUND
JMF
-17,789
Closed -$26K
EXIV
2539
DELISTED
VelocityShares 1x Daily Inverse VSTOXX Futures ETN
EXIV
-10,050
Closed -$74K
RTN
2540
DELISTED
Raytheon Company
RTN
-55,196
Closed -$7.24M
S
2541
DELISTED
Sprint Corporation
S
-16,518
Closed -$142K
HZNP
2542
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
-10,463
Closed -$310K
PDLI
2543
DELISTED
PDL BioPharma, Inc.
PDLI
-13,082
Closed -$37K
UFS
2544
DELISTED
DOMTAR CORPORATION (New)
UFS
-20,274
Closed -$439K
CHL
2545
DELISTED
China Mobile Limited
CHL
-11,694
Closed -$441K
FTR
2546
DELISTED
Frontier Communications Corp.
FTR
-15,063
Closed -$6K
CY
2547
DELISTED
Cypress Semiconductor
CY
-31,855
Closed -$743K
OIL
2548
DELISTED
iPath Series B S&P GSCI Crude Oil ETN
OIL
-36,815
Closed -$152K

Similar funds

Cambridge Investment Research Advisors's Q2 2020 Portfolio in Review

As of Q2 2020, Cambridge Investment Research Advisors held 2,557 positions worth $13.3B, up 28% from $10.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $1.1B of net new capital in Q2 2020, opening 285 new positions and adding to 1,225 existing holdings. Its largest new stake was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.

By sector, the portfolio is most concentrated in Technology at 9% of assets, up from 8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Vanguard Short-Term Treasury ETF, an estimated $50.5M trimmed.

  • Cambridge Investment Research Advisors's largest Q2 2020 buy was FS KKR Capital Corp. II: 1,991,449 shares worth $25.7M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q2 2020, an estimated $87.9M increase.
  • Cambridge Investment Research Advisors's biggest Q2 2020 reduction was Vanguard Short-Term Treasury ETF, cutting an estimated $50.5M.
  • Cambridge Investment Research Advisors fully exited Raytheon Company in Q2 2020, selling an estimated $7.24M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $13.3B portfolio in Q2 2020.
  • Cambridge Investment Research Advisors opened 285 new positions and closed 103 in Q2 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 28% quarter-over-quarter to $13.3B.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2020, filed 27 Jul 2020.